Gregory Licholai
Chief Tech/Sci/R&D Officer bij ICON PUBLIC LIMITED COMPANY
Profiel
Gregory P. Licholai, oprichter van Immunome, Inc., is momenteel Chief Medical & Innovation Officer bij ICON plc en President van Elpidera LLC. Dr. Licholai zit ook in de raad van bestuur van Sollis Therapeutics, Inc. Daarvoor was hij President & Chief Scientific Officer bij Castle Creek Pharmaceuticals LLC, Vice President-Medical Affairs bij Amicus Therapeutics, Inc., Director-Ventures & Business Associates bij Medtronic Neurological en Director bij Immunome, Inc. Gregory P. Licholai behaalde een bachelor aan het Boston College, een doctoraat aan de Yale University en een MBA aan de Harvard University.
Actieve functies van Gregory Licholai
| Bedrijven | Functie | Begin |
|---|---|---|
| ICON PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 01-11-2021 |
| Elpidera LLC | President | - |
Eerdere bekende functies van Gregory Licholai
| Bedrijven | Functie | Einde |
|---|---|---|
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | President | 01-02-2018 |
| AMICUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02-10-2009 |
| Medtronic Neurological | Corporate Officer/Principal | 01-11-2002 |
| MODERNA, INC. | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Opleiding van Gregory Licholai
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Boston College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
| Yale School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| IMMUNOME, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
| Medtronic Neurological | |
| Elpidera LLC | |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
